BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
NEUROG3
,
T cell differentiation
,
Hepatitis
,
Pancreas
,
Avian flu virus
,
Lovastatin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
plasma cell myeloma
Summary
General Info
Curated Studies
Most Correlated Studies
MMRC expression reference collection of newly diagnosed and relapsed multiple myeloma patients
GSK cancer cell line transcript profiling
Gene expression profiling and correlation with outcome in clinical trials of bortezomib in myeloma
Myeloma OPM-2 cells with conditional IKZF1 or IKZF3 knockout or treated with lenalidomide
Multiple myeloma cell lines treated with 5-aza-2-deoxycytidine or trichostatin A
Explore Curated Studies Results
Literature
Most Relevant Literature
Are we ready to look beyond plasma cells in assessing high-risk smoldering myeloma?
Flaming" Plasma Cells in a 28-Year-Old Man with Non-Secretory Multiple Myeloma.
MM-218 Plasma Cell Myeloma-Associated Crystal-Storing Histiocytosis.
Dual Expression of Immunoglobulin Light Chains in Plasma Cell Myeloma: A Case Report and Literature …
More than 2% circulating plasma cells as a prognostic biomarker in a large cohort of patients with n…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Carfilzomib and Stem Cell Transplant for Plasma Cell Myeloma
Lenalidomide Maintenance in Plasma Cell Myeloma
Isatuximab in Treating Patients With High Risk Smoldering Plasma Cell Myeloma
Collection of Transplant Stem Cells for Plasma Cell Myeloma
Assess the Safety and Efficacy of CT0594CP Cells in Relapsed/Refractory Multiple Myeloma or Plasma C…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ